AU Patent

AU2004325362B2 — Process of preparation of biodegradable films from semi refined kappa carrageenan

Assigned to Council of Scientific and Industrial Research CSIR · Expires 2012-09-06 · 14y expired

What this patent protects

The present invention relates to use of inexpensive semi-refined kappa carrageenan as a seaweed polysaccharide in preparation of tough, biodegradable films exhibiting improved performance over films obtained from refined kappa carrageenan. The formulation requires no gelling salt…

USPTO Abstract

The present invention relates to use of inexpensive semi-refined kappa carrageenan as a seaweed polysaccharide in preparation of tough, biodegradable films exhibiting improved performance over films obtained from refined kappa carrageenan. The formulation requires no gelling salt and the only other essential components of the film are glycerol and water, the former being used as plasticizer as reported in the prior art. The films can be recycled and reprocessed if required. The performance of the films can be further enhanced by incorporating polyvinyl alcohol that lends toughness and clarity as also natural rubber latex that imparts greater elasticity and barrier properties. Films of optimum composition can be pulse heat sealed immediately after casting and used for preparation of soft capsules and pouches. It is possible to store solvents and oils in the pouches. In view of the more eco­friendly processing of semi-refined kappa carrageenan compared to refined kappa carrageenan, films made with the former would also effectively be "greener".

Drugs covered by this patent

Patent Metadata

Patent number
AU2004325362B2
Jurisdiction
AU
Classification
Expires
2012-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Council of Scientific and Industrial Research CSIR
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.